16
Participants
Start Date
September 30, 2003
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
megadose oral methylprednisolone
1400 mg qd/5 days
IV methylprednisolone
1000 mg/qd/5 days
Hospital For Joint Diseases, New York
St. Luke's Roosevelt, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
NY Presbyterian Hospital-Cornell University New York, New York
Maimonides Medical Center, Brooklyn
The Jacobs Neurological Institute, Buffalo
University of Rochester, Rochester
University of Medicine and Dentistry of New Jersey, New Brunswick
University of Vermont, Burlington, Burlington
Lead Sponsor
Collaborators (1)
National Multiple Sclerosis Society
OTHER
Pfizer
INDUSTRY
Fred Lublin
OTHER